Recombinant Human Growth Hormone (rhGH)

Recombinant Human Growth Hormone (rhGH)

Recombinant human growth hormone (rhGH) is a synthetic version of the endogenous growth hormone produced by the anterior pituitary gland. It plays a crucial role in promoting linear growth, metabolism, and body composition.

Key Points

  • Molecular Weight: 22 kDa
  • Half-life: 2-3 hours
  • Route: Subcutaneous injection
  • Frequency: Daily administration

Mechanism of Action

  • Direct effects:
    • Stimulates hepatic IGF-1 production
    • Promotes chondrocyte proliferation
    • Enhances amino acid uptake
    • Increases protein synthesis
  • Indirect effects through IGF-1:
    • Stimulates longitudinal bone growth
    • Promotes cell differentiation
    • Enhances muscle growth
    • Improves bone mineralization
  • Metabolic effects:
    • Increases lipolysis
    • Promotes protein anabolism
    • Enhances glucose metabolism

Clinical Indications

FDA-Approved Indications:

  • Growth Hormone Deficiency (GHD)
    • Congenital
    • Acquired
    • Idiopathic
  • Turner Syndrome
  • Prader-Willi Syndrome
  • Small for Gestational Age (SGA) without catch-up growth
  • SHOX deficiency
  • Chronic Renal Insufficiency
  • Idiopathic Short Stature (ISS)
  • Noonan Syndrome

Dosing & Administration

Standard Dosing by Indication:

  • GH Deficiency: 0.024-0.034 mg/kg/day
  • Turner Syndrome: 0.05 mg/kg/day
  • Prader-Willi Syndrome: 0.035 mg/kg/day
  • SGA: 0.035-0.067 mg/kg/day
  • Chronic Renal Insufficiency: 0.05 mg/kg/day
  • SHOX deficiency: 0.05 mg/kg/day
  • ISS: 0.034-0.067 mg/kg/day

Administration Guidelines:

  • Subcutaneous injection
  • Rotate injection sites
  • Evening administration preferred
  • Store refrigerated (2-8°C)

Monitoring & Safety

Regular Monitoring:

  • Growth velocity
  • Height and weight
  • IGF-1 levels
  • Bone age (annually)
  • Thyroid function
  • Glucose metabolism
  • Spine examination for scoliosis

Common Side Effects:

  • Injection site reactions
  • Headache
  • Hip pain
  • Arthralgia
  • Peripheral edema
  • Insulin resistance

Serious Adverse Events:

  • Intracranial hypertension
  • Slipped capital femoral epiphysis
  • Scoliosis progression
  • Pancreatitis

Contraindications & Precautions

Absolute Contraindications:

  • Active malignancy
  • Active proliferative or severe non-proliferative diabetic retinopathy
  • Acute critical illness
  • Closed epiphyses

Relative Contraindications:

  • Severe scoliosis
  • Severe obesity
  • Uncontrolled diabetes
  • Sleep apnea

Special Populations:

  • PWS patients with severe obesity
  • History of malignancy
  • Concurrent glucocorticoid therapy


Further Reading
Powered by Blogger.